nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—leg—melanoma	0.0827	0.18	CbGeAlD
Amifostine—ALPPL2—hindlimb—melanoma	0.0739	0.16	CbGeAlD
Amifostine—ALPPL2—arm—melanoma	0.0706	0.153	CbGeAlD
Amifostine—ALPPL2—appendage—melanoma	0.0634	0.138	CbGeAlD
Amifostine—ALPPL2—endothelium—melanoma	0.0383	0.0831	CbGeAlD
Amifostine—ALPPL2—blood vessel—melanoma	0.0353	0.0766	CbGeAlD
Amifostine—ALPPL2—neck—melanoma	0.0252	0.0548	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—CDKN1C—melanoma	0.0209	0.0614	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—CDKN1C—melanoma	0.0178	0.0522	CbGpPWpGaD
Amifostine—ENPP1—skin of body—melanoma	0.0169	0.0368	CbGeAlD
Amifostine—ALPPL2—skin of body—melanoma	0.0163	0.0355	CbGeAlD
Amifostine—ENPP1—Insulin Signaling—MAP3K9—melanoma	0.0149	0.0437	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—NOTCH1—melanoma	0.0124	0.0364	CbGpPWpGaD
Amifostine—ENPP1—head—melanoma	0.0111	0.024	CbGeAlD
Amifostine—ALPPL2—head—melanoma	0.0107	0.0231	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—COL2A1—melanoma	0.0106	0.031	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—LGALS3—melanoma	0.00987	0.029	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—CUBN—melanoma	0.00927	0.0272	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—COL2A1—melanoma	0.00898	0.0264	CbGpPWpGaD
Amifostine—ALPL—lymph node—melanoma	0.00843	0.0183	CbGeAlD
Amifostine—Rigors—Vemurafenib—melanoma	0.00839	0.0421	CcSEcCtD
Amifostine—ENPP1—lymph node—melanoma	0.00774	0.0168	CbGeAlD
Amifostine—ALPL—AGE/RAGE pathway—FOXO4—melanoma	0.00727	0.0214	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—melanoma	0.00725	0.0213	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—BCL2L11—melanoma	0.00585	0.0172	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—SPP1—melanoma	0.00525	0.0154	CbGpPWpGaD
Amifostine—Atrial fibrillation—Vemurafenib—melanoma	0.00525	0.0263	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—PRKCA—melanoma	0.00523	0.0154	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—FASN—melanoma	0.00516	0.0152	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CDH2—melanoma	0.00501	0.0147	CbGpPWpGaD
Amifostine—Chest tightness—Docetaxel—melanoma	0.00496	0.0249	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAP3K5—melanoma	0.0049	0.0144	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—RAC1—melanoma	0.00485	0.0142	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—melanoma	0.00465	0.0137	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00448	0.0225	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—SPP1—melanoma	0.00447	0.0131	CbGpPWpGaD
Amifostine—Rigors—Temozolomide—melanoma	0.00429	0.0215	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—PTK2B—melanoma	0.00426	0.0125	CbGpPWpGaD
Amifostine—Hypocalcaemia—Dactinomycin—melanoma	0.00423	0.0212	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—NOS2—melanoma	0.00423	0.0124	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—RAC2—melanoma	0.0041	0.012	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1—melanoma	0.00384	0.0113	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP8—melanoma	0.00381	0.0112	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0038	0.0191	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—melanoma	0.00363	0.0107	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAP2K1—melanoma	0.00362	0.0106	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NGFR—melanoma	0.00356	0.0105	CbGpPWpGaD
Amifostine—Supraventricular tachycardia—Docetaxel—melanoma	0.00355	0.0178	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—FGF2—melanoma	0.00353	0.0104	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1—melanoma	0.00327	0.0096	CbGpPWpGaD
Amifostine—Erythema multiforme—Vemurafenib—melanoma	0.00325	0.0163	CcSEcCtD
Amifostine—Chills—Vemurafenib—melanoma	0.00309	0.0155	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—FGF2—melanoma	0.003	0.00883	CbGpPWpGaD
Amifostine—Myocardial ischaemia—Docetaxel—melanoma	0.0029	0.0145	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—melanoma	0.00288	0.00848	CbGpPWpGaD
Amifostine—Rigors—Docetaxel—melanoma	0.00285	0.0143	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—MMP9—melanoma	0.00279	0.00821	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—SPP1—melanoma	0.00275	0.00807	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAP2K2—melanoma	0.00274	0.00805	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—melanoma	0.00273	0.00801	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NFKB1—melanoma	0.0027	0.00793	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Temozolomide—melanoma	0.00269	0.0135	CcSEcCtD
Amifostine—Chest discomfort—Docetaxel—melanoma	0.00263	0.0132	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—RAC1—melanoma	0.0026	0.00763	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—SOCS1—melanoma	0.00257	0.00757	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00253	0.0127	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—VEGFA—melanoma	0.00251	0.00738	CbGpPWpGaD
Amifostine—Anaphylactic shock—Vemurafenib—melanoma	0.00244	0.0123	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—melanoma	0.00242	0.00713	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—melanoma	0.00238	0.00698	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAPK3—melanoma	0.00232	0.00681	CbGpPWpGaD
Amifostine—Acute coronary syndrome—Bleomycin—melanoma	0.00229	0.0115	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00229	0.0115	CcSEcCtD
Amifostine—Hypotension—Vemurafenib—melanoma	0.00228	0.0115	CcSEcCtD
Amifostine—Myocardial infarction—Bleomycin—melanoma	0.00228	0.0114	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MAPK1—melanoma	0.0022	0.00648	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—melanoma	0.0022	0.00648	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—APC—melanoma	0.00219	0.00645	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PRKCA—melanoma	0.00219	0.00643	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYO7A—melanoma	0.00217	0.00638	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00215	0.0108	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAP2K2—melanoma	0.00214	0.00629	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—melanoma	0.00213	0.00627	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—melanoma	0.00212	0.00623	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—RAC1—melanoma	0.00203	0.00596	CbGpPWpGaD
Amifostine—Renal failure—Carmustine—melanoma	0.00199	0.00999	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00194	0.00974	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAP2K1—melanoma	0.00194	0.0057	CbGpPWpGaD
Amifostine—Flushing—Bleomycin—melanoma	0.00193	0.0097	CcSEcCtD
Amifostine—Body temperature increased—Vemurafenib—melanoma	0.00193	0.00969	CcSEcCtD
Amifostine—Chills—Bleomycin—melanoma	0.00187	0.00938	CcSEcCtD
Amifostine—ENPP1—Disease—HS3ST5—melanoma	0.00184	0.00542	CbGpPWpGaD
Amifostine—Erythema multiforme—Dactinomycin—melanoma	0.00184	0.00922	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACER3—melanoma	0.00182	0.00534	CbGpPWpGaD
Amifostine—Flushing—Dactinomycin—melanoma	0.0018	0.00905	CcSEcCtD
Amifostine—Hypersensitivity—Vemurafenib—melanoma	0.0018	0.00903	CcSEcCtD
Amifostine—Atrial fibrillation—Docetaxel—melanoma	0.00178	0.00895	CcSEcCtD
Amifostine—Chills—Dactinomycin—melanoma	0.00174	0.00875	CcSEcCtD
Amifostine—Pruritus—Vemurafenib—melanoma	0.00173	0.00867	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—melanoma	0.00171	0.00504	CbGpPWpGaD
Amifostine—Flushing—Carmustine—melanoma	0.00169	0.00847	CcSEcCtD
Amifostine—Ill-defined disorder—Bleomycin—melanoma	0.00168	0.00844	CcSEcCtD
Amifostine—Erythema multiforme—Temozolomide—melanoma	0.00166	0.00834	CcSEcCtD
Amifostine—ENPP1—Metabolism—UGT2B10—melanoma	0.00166	0.00488	CbGpPWpGaD
Amifostine—Malaise—Bleomycin—melanoma	0.00164	0.00821	CcSEcCtD
Amifostine—Flushing—Temozolomide—melanoma	0.00163	0.00819	CcSEcCtD
Amifostine—Arrhythmia—Carmustine—melanoma	0.00162	0.00815	CcSEcCtD
Amifostine—Dizziness—Vemurafenib—melanoma	0.00162	0.00811	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—melanoma	0.0016	0.00471	CbGpPWpGaD
Amifostine—Chills—Temozolomide—melanoma	0.00158	0.00791	CcSEcCtD
Amifostine—Ill-defined disorder—Dactinomycin—melanoma	0.00157	0.00788	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—melanoma	0.00156	0.00459	CbGpPWpGaD
Amifostine—Vomiting—Vemurafenib—melanoma	0.00155	0.0078	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CASP3—melanoma	0.00155	0.00454	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HS3ST5—melanoma	0.00154	0.00454	CbGpPWpGaD
Amifostine—Chest pain—Bleomycin—melanoma	0.00154	0.00775	CcSEcCtD
Amifostine—Rash—Vemurafenib—melanoma	0.00154	0.00773	CcSEcCtD
Amifostine—Dermatitis—Vemurafenib—melanoma	0.00154	0.00772	CcSEcCtD
Amifostine—Discomfort—Bleomycin—melanoma	0.00153	0.00766	CcSEcCtD
Amifostine—Malaise—Dactinomycin—melanoma	0.00153	0.00765	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00152	0.00763	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAP2K1—melanoma	0.00152	0.00446	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—melanoma	0.00151	0.00443	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—melanoma	0.00149	0.00438	CbGpPWpGaD
Amifostine—Anaphylactic shock—Bleomycin—melanoma	0.00148	0.00743	CcSEcCtD
Amifostine—Nausea—Vemurafenib—melanoma	0.00145	0.00728	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—NFKB1—melanoma	0.00145	0.00425	CbGpPWpGaD
Amifostine—Discomfort—Dactinomycin—melanoma	0.00142	0.00714	CcSEcCtD
Amifostine—Ill-defined disorder—Temozolomide—melanoma	0.00142	0.00712	CcSEcCtD
Amifostine—Hypotension—Bleomycin—melanoma	0.00138	0.00694	CcSEcCtD
Amifostine—Malaise—Temozolomide—melanoma	0.00138	0.00692	CcSEcCtD
Amifostine—Convulsion—Carmustine—melanoma	0.00137	0.00688	CcSEcCtD
Amifostine—Hypertension—Carmustine—melanoma	0.00137	0.00686	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—AKT1—melanoma	0.00136	0.004	CbGpPWpGaD
Amifostine—Chest pain—Carmustine—melanoma	0.00135	0.00676	CcSEcCtD
Amifostine—Convulsion—Temozolomide—melanoma	0.00133	0.00665	CcSEcCtD
Amifostine—Hypertension—Temozolomide—melanoma	0.00132	0.00663	CcSEcCtD
Amifostine—Dyspnoea—Bleomycin—melanoma	0.00132	0.00662	CcSEcCtD
Amifostine—ENPP1—Disease—TRRAP—melanoma	0.00131	0.00386	CbGpPWpGaD
Amifostine—ENPP1—Disease—CUL3—melanoma	0.00131	0.00386	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—melanoma	0.00131	0.00386	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT3—melanoma	0.0013	0.00382	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00129	0.00648	CcSEcCtD
Amifostine—Discomfort—Temozolomide—melanoma	0.00129	0.00646	CcSEcCtD
Amifostine—Acute coronary syndrome—Docetaxel—melanoma	0.00128	0.00644	CcSEcCtD
Amifostine—Renal failure—Docetaxel—melanoma	0.00128	0.00642	CcSEcCtD
Amifostine—ENPP1—Disease—AKR1B10—melanoma	0.00128	0.00376	CbGpPWpGaD
Amifostine—Myocardial infarction—Docetaxel—melanoma	0.00128	0.0064	CcSEcCtD
Amifostine—Tachycardia—Carmustine—melanoma	0.00126	0.00633	CcSEcCtD
Amifostine—Anaphylactic shock—Temozolomide—melanoma	0.00125	0.00627	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK3—melanoma	0.00124	0.00365	CbGpPWpGaD
Amifostine—Feeling abnormal—Bleomycin—melanoma	0.00122	0.00612	CcSEcCtD
Amifostine—Hypotension—Carmustine—melanoma	0.00121	0.00606	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK1—melanoma	0.00118	0.00347	CbGpPWpGaD
Amifostine—Urticaria—Bleomycin—melanoma	0.00118	0.0059	CcSEcCtD
Amifostine—ENPP1—Metabolism—PLCB4—melanoma	0.00117	0.00344	CbGpPWpGaD
Amifostine—Body temperature increased—Bleomycin—melanoma	0.00117	0.00587	CcSEcCtD
Amifostine—Dyspnoea—Carmustine—melanoma	0.00115	0.00578	CcSEcCtD
Amifostine—Somnolence—Carmustine—melanoma	0.00115	0.00576	CcSEcCtD
Amifostine—ENPP1—Disease—LUM—melanoma	0.00114	0.00335	CbGpPWpGaD
Amifostine—Feeling abnormal—Dactinomycin—melanoma	0.00114	0.00571	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PTEN—melanoma	0.00113	0.00334	CbGpPWpGaD
Amifostine—ENPP1—Disease—HPSE—melanoma	0.00112	0.00328	CbGpPWpGaD
Amifostine—Dyspnoea—Temozolomide—melanoma	0.00111	0.00559	CcSEcCtD
Amifostine—Somnolence—Temozolomide—melanoma	0.00111	0.00557	CcSEcCtD
Amifostine—Erythema multiforme—Docetaxel—melanoma	0.00111	0.00555	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC6A11—melanoma	0.0011	0.00324	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIP4K2A—melanoma	0.0011	0.00324	CbGpPWpGaD
Amifostine—ENPP1—Disease—CUBN—melanoma	0.0011	0.00322	CbGpPWpGaD
Amifostine—Body temperature increased—Dactinomycin—melanoma	0.00109	0.00548	CcSEcCtD
Amifostine—Hypersensitivity—Bleomycin—melanoma	0.00109	0.00547	CcSEcCtD
Amifostine—Flushing—Docetaxel—melanoma	0.00108	0.00544	CcSEcCtD
Amifostine—ENPP1—Metabolism—MTAP—melanoma	0.00107	0.00315	CbGpPWpGaD
Amifostine—Feeling abnormal—Carmustine—melanoma	0.00106	0.00534	CcSEcCtD
Amifostine—ENPP1—Disease—CSPG4—melanoma	0.00106	0.00311	CbGpPWpGaD
Amifostine—Chills—Docetaxel—melanoma	0.00105	0.00526	CcSEcCtD
Amifostine—Pruritus—Bleomycin—melanoma	0.00105	0.00526	CcSEcCtD
Amifostine—Arrhythmia—Docetaxel—melanoma	0.00104	0.00524	CcSEcCtD
Amifostine—ENPP1—Disease—RPS3—melanoma	0.00104	0.00306	CbGpPWpGaD
Amifostine—Feeling abnormal—Temozolomide—melanoma	0.00103	0.00516	CcSEcCtD
Amifostine—ENPP1—Disease—SKI—melanoma	0.00103	0.00302	CbGpPWpGaD
Amifostine—Body temperature increased—Carmustine—melanoma	0.00102	0.00513	CcSEcCtD
Amifostine—Hypersensitivity—Dactinomycin—melanoma	0.00102	0.0051	CcSEcCtD
Amifostine—Urticaria—Temozolomide—melanoma	0.000992	0.00498	CcSEcCtD
Amifostine—Body temperature increased—Temozolomide—melanoma	0.000987	0.00495	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK3—melanoma	0.00097	0.00285	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LUM—melanoma	0.000954	0.00281	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PHGDH—melanoma	0.000954	0.00281	CbGpPWpGaD
Amifostine—Hypersensitivity—Carmustine—melanoma	0.000952	0.00478	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—melanoma	0.000948	0.00279	CbGpPWpGaD
Amifostine—Vomiting—Bleomycin—melanoma	0.000941	0.00472	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPSE—melanoma	0.000936	0.00275	CbGpPWpGaD
Amifostine—Rash—Bleomycin—melanoma	0.000933	0.00468	CcSEcCtD
Amifostine—Dermatitis—Bleomycin—melanoma	0.000933	0.00468	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK1—melanoma	0.000923	0.00271	CbGpPWpGaD
Amifostine—Hypersensitivity—Temozolomide—melanoma	0.00092	0.00462	CcSEcCtD
Amifostine—ENPP1—Metabolism—CUBN—melanoma	0.000919	0.0027	CbGpPWpGaD
Amifostine—Syncope—Docetaxel—melanoma	0.000913	0.00458	CcSEcCtD
Amifostine—Loss of consciousness—Docetaxel—melanoma	0.000894	0.00449	CcSEcCtD
Amifostine—ENPP1—Metabolism—SDHD—melanoma	0.000887	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—BSG—melanoma	0.000887	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CSPG4—melanoma	0.000887	0.00261	CbGpPWpGaD
Amifostine—Pruritus—Temozolomide—melanoma	0.000884	0.00443	CcSEcCtD
Amifostine—Convulsion—Docetaxel—melanoma	0.000882	0.00442	CcSEcCtD
Amifostine—Nausea—Bleomycin—melanoma	0.000879	0.00441	CcSEcCtD
Amifostine—Hypertension—Docetaxel—melanoma	0.000879	0.00441	CcSEcCtD
Amifostine—Vomiting—Dactinomycin—melanoma	0.000878	0.0044	CcSEcCtD
Amifostine—Rash—Dactinomycin—melanoma	0.000871	0.00437	CcSEcCtD
Amifostine—Chest pain—Docetaxel—melanoma	0.000866	0.00435	CcSEcCtD
Amifostine—ENPP1—Metabolism—GPAM—melanoma	0.000859	0.00253	CbGpPWpGaD
Amifostine—Dizziness—Carmustine—melanoma	0.000855	0.00429	CcSEcCtD
Amifostine—ENPP1—Disease—HDAC6—melanoma	0.000847	0.00249	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—AKT1—melanoma	0.000837	0.00246	CbGpPWpGaD
Amifostine—Anaphylactic shock—Docetaxel—melanoma	0.00083	0.00417	CcSEcCtD
Amifostine—Dizziness—Temozolomide—melanoma	0.000826	0.00414	CcSEcCtD
Amifostine—Vomiting—Carmustine—melanoma	0.000822	0.00412	CcSEcCtD
Amifostine—Nausea—Dactinomycin—melanoma	0.00082	0.00412	CcSEcCtD
Amifostine—Shock—Docetaxel—melanoma	0.000817	0.0041	CcSEcCtD
Amifostine—Rash—Carmustine—melanoma	0.000815	0.00409	CcSEcCtD
Amifostine—Dermatitis—Carmustine—melanoma	0.000814	0.00408	CcSEcCtD
Amifostine—Tachycardia—Docetaxel—melanoma	0.000811	0.00407	CcSEcCtD
Amifostine—ENPP1—Disease—NPPA—melanoma	0.000803	0.00236	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—melanoma	0.000801	0.00235	CbGpPWpGaD
Amifostine—Vomiting—Temozolomide—melanoma	0.000794	0.00398	CcSEcCtD
Amifostine—Rash—Temozolomide—melanoma	0.000787	0.00395	CcSEcCtD
Amifostine—Dermatitis—Temozolomide—melanoma	0.000787	0.00395	CcSEcCtD
Amifostine—ENPP1—Disease—VCAN—melanoma	0.000784	0.0023	CbGpPWpGaD
Amifostine—ENPP1—Disease—WNT5A—melanoma	0.000778	0.00229	CbGpPWpGaD
Amifostine—Hypotension—Docetaxel—melanoma	0.000776	0.00389	CcSEcCtD
Amifostine—Nausea—Carmustine—melanoma	0.000768	0.00385	CcSEcCtD
Amifostine—Nausea—Temozolomide—melanoma	0.000742	0.00372	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—HRAS—melanoma	0.000741	0.00218	CbGpPWpGaD
Amifostine—Dyspnoea—Docetaxel—melanoma	0.00074	0.00372	CcSEcCtD
Amifostine—Somnolence—Docetaxel—melanoma	0.000738	0.0037	CcSEcCtD
Amifostine—ENPP1—Metabolism—PLA2G6—melanoma	0.000731	0.00215	CbGpPWpGaD
Amifostine—Feeling abnormal—Docetaxel—melanoma	0.000684	0.00343	CcSEcCtD
Amifostine—Body temperature increased—Docetaxel—melanoma	0.000656	0.00329	CcSEcCtD
Amifostine—ENPP1—Metabolism—VCAN—melanoma	0.000656	0.00193	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT1—melanoma	0.000654	0.00192	CbGpPWpGaD
Amifostine—ENPP1—Disease—GAB2—melanoma	0.000624	0.00184	CbGpPWpGaD
Amifostine—Hypersensitivity—Docetaxel—melanoma	0.000612	0.00307	CcSEcCtD
Amifostine—ENPP1—Disease—FASN—melanoma	0.000611	0.0018	CbGpPWpGaD
Amifostine—Pruritus—Docetaxel—melanoma	0.000588	0.00295	CcSEcCtD
Amifostine—ENPP1—Disease—HDAC2—melanoma	0.000587	0.00173	CbGpPWpGaD
Amifostine—ENPP1—Disease—FOXO4—melanoma	0.000587	0.00173	CbGpPWpGaD
Amifostine—ENPP1—Disease—CXCR4—melanoma	0.000587	0.00173	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD44—melanoma	0.00058	0.00171	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP17A1—melanoma	0.000554	0.00163	CbGpPWpGaD
Amifostine—Dizziness—Docetaxel—melanoma	0.000549	0.00276	CcSEcCtD
Amifostine—ENPP1—Disease—AKT3—melanoma	0.000536	0.00157	CbGpPWpGaD
Amifostine—Vomiting—Docetaxel—melanoma	0.000528	0.00265	CcSEcCtD
Amifostine—Rash—Docetaxel—melanoma	0.000524	0.00263	CcSEcCtD
Amifostine—Dermatitis—Docetaxel—melanoma	0.000523	0.00262	CcSEcCtD
Amifostine—ENPP1—Metabolism—GNA11—melanoma	0.000523	0.00154	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—FASN—melanoma	0.000512	0.0015	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A5—melanoma	0.000503	0.00148	CbGpPWpGaD
Amifostine—Nausea—Docetaxel—melanoma	0.000493	0.00248	CcSEcCtD
Amifostine—ENPP1—Metabolism—GNAQ—melanoma	0.000486	0.00143	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CD44—melanoma	0.000486	0.00143	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB4—melanoma	0.000473	0.00139	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN2B—melanoma	0.000469	0.00138	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP1B1—melanoma	0.000466	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD86—melanoma	0.000454	0.00133	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGF1—melanoma	0.00044	0.00129	CbGpPWpGaD
Amifostine—ENPP1—Disease—PDGFRA—melanoma	0.000426	0.00125	CbGpPWpGaD
Amifostine—ENPP1—Disease—PRKCA—melanoma	0.000422	0.00124	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERCC2—melanoma	0.000418	0.00123	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAP2K2—melanoma	0.000412	0.00121	CbGpPWpGaD
Amifostine—ENPP1—Disease—TERT—melanoma	0.000392	0.00115	CbGpPWpGaD
Amifostine—ENPP1—Disease—HLA-A—melanoma	0.000392	0.00115	CbGpPWpGaD
Amifostine—ENPP1—Disease—RAC1—melanoma	0.000391	0.00115	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCB1—melanoma	0.000384	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—melanoma	0.000375	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PRKCA—melanoma	0.000353	0.00104	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ERCC2—melanoma	0.00035	0.00103	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS2—melanoma	0.000341	0.001	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOTCH1—melanoma	0.000338	0.000993	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD80—melanoma	0.000331	0.000973	CbGpPWpGaD
Amifostine—ENPP1—Disease—KIT—melanoma	0.00033	0.000971	CbGpPWpGaD
Amifostine—ENPP1—Disease—APC—melanoma	0.00033	0.000971	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGF—melanoma	0.000327	0.00096	CbGpPWpGaD
Amifostine—ENPP1—Disease—BRAF—melanoma	0.00031	0.000913	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAP2K1—melanoma	0.000292	0.000859	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CD—melanoma	0.00029	0.000854	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGF2—melanoma	0.000278	0.000817	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CG—melanoma	0.000277	0.000813	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARG—melanoma	0.000267	0.000785	CbGpPWpGaD
Amifostine—ENPP1—Disease—MDM2—melanoma	0.00026	0.000765	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB2—melanoma	0.000256	0.000754	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CB—melanoma	0.000253	0.000744	CbGpPWpGaD
Amifostine—ENPP1—Disease—CD4—melanoma	0.000253	0.000743	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—melanoma	0.000251	0.000737	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CD—melanoma	0.000243	0.000715	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ALB—melanoma	0.00024	0.000706	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—melanoma	0.000238	0.000698	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—melanoma	0.000224	0.00066	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1A—melanoma	0.000219	0.000644	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—melanoma	0.000219	0.000643	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CB—melanoma	0.000212	0.000623	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—melanoma	0.00021	0.000617	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—melanoma	0.000196	0.000575	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—melanoma	0.000195	0.000574	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK3—melanoma	0.000187	0.000549	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—melanoma	0.000183	0.000538	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—melanoma	0.000182	0.000534	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK1—melanoma	0.000178	0.000523	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—melanoma	0.000178	0.000523	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—melanoma	0.000168	0.000494	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—melanoma	0.000154	0.000454	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—melanoma	0.000143	0.00042	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—melanoma	0.000137	0.000402	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—melanoma	0.000129	0.00038	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—melanoma	0.000126	0.000371	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—melanoma	0.000106	0.00031	CbGpPWpGaD
